Cargando…
免疫检查点抑制剂在小细胞肺癌治疗中的应用与临床试验进展
Small cell lung cancer (SCLC) is a neuroendocrine tumor with fast progression, high malignancy, easy recurrence, and extremely poor prognosis. In the past 30 years, the clinical treatment strategy of SCLC has been mainly chemotherapy and radiotherapy, but the curative effect is not significant; the...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607286/ https://www.ncbi.nlm.nih.gov/pubmed/34802211 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.41 |